Antibody

41개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved41 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleMassachusetts General HospitalPhase 3

Encorafenib/Binimetinib/Cetuximab Protocol (Encorafenib/Binimetinib/Cetuximab Protocol)

Metastatic Colon Cancer; Stage III Colon Cancer · Metastatic Colon Cancer

#MetastaticColonCancer#Antibody#Phase3#monoclonal-antibody#StageIIIColonCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleGregory DanielsPhase 2

nivolumab (Opdivo, IL-2 and Nivolumab)

Melanoma Stage Iv; Renal Cell Carcinoma, Metastatic · Melanoma Stage Iv

#MelanomaStageIv#Antibody#Phase2#monoclonal-antibody#RenalCellCarcinoma+2
Trials 1Status Discontinued
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

Ipilimumab IT (Ipilimumab IT)

Stage III/IV Melanoma · Stage III/IV Melanoma

#StageIIIIVMelanoma#Antibody#Phase2#monoclonal-antibody#StageIII+2
Trials 1Status Active
AntibodyLimited DatastaleOslo University HospitalPhase 2

pembrolizumab (Keytruda, LTX-315 + pembrolizumab)

Melanoma Stage IIIB-IV · Melanoma Stage IIIB-IV

#MelanomaStageIIIB-IV#Antibody#Phase2#monoclonal-antibody#Oslo
Trials 1Status Recruiting
AntibodyLimited DatastaleCentre Hospitalier Departementa…Phase 3

Maintenance (Maintenance, Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®, or initiation)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; End Stage Renal Disease · Anti-Neutrophil Cytoplasmic Antibody-Ass

#Anti-NeutrophilCytoplasmicAntibo#Antibody#Phase3#monoclonal-antibody#EndStageRenalDisease+1
Trials 1Status Recruiting
AntibodyLimited DatastaleAstraZenecaPhase 2

durvalumab (Imfinzi, Neoadjuvant chemotherapy+Durvalumab+Tremelimumab)

Ovarian Cancer Stage IIIC; Ovarian Cancer Stage IV · Ovarian Cancer Stage IIIC

#OvarianCancerStageIIIC#Antibody#Phase2#monoclonal-antibody#OvarianCancerStageIV+1
Trials 1Status Active
AntibodyLimited DatastaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, Neoadjuvant ipilimumab + nivolumab)

Malignant Melanoma Stage III · Malignant Melanoma Stage III

#MalignantMelanomaStageIII#Antibody#Phase3#monoclonal-antibody#Bristol
Trials 1Status Recruiting
AntibodyLimited DatastaleWashington University School of…Phase 2

Nogapendekin alfa inbakicept (Nogapendekin alfa inbakicept)

Non-small Cell Lung Cancer Stage IV; Non-small Cell Lung Cancer Recurrent · Non-small Cell Lung Cancer Stage IV

#Non-smallCellLungCancerStageIV#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancerRecurrent+1
Trials 1Status Recruiting
AntibodyLimited DatastaleThe First Affiliated Hospital w…Phase 2

Iparomlimab/Tuvonralimab (QL1706, QL1706 (Iparomlimab/Tuvonralimab))

Gastric Cancer Stage III · Gastric Cancer Stage III

#GastricCancerStageIII#Antibody#Phase2#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleSWOG Cancer Research NetworkPreclinical

Rilotumumab (Rilotumumab)

Recurrent Squamous Cell Lung Carcinoma; Stage IV Squamous Cell Lung Carcinoma AJCC v7 · Recurrent Squamous Cell Lung Carcinoma

#RecurrentSquamousCellLungCarcino#Antibody#Preclinical#monoclonal-antibody#StageIVSquamousCellLungCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleAmsterdam UMC, location VUmcPhase 2

pembrolizumab (Keytruda, SABR + pembrolizumab)

NSCLC, Stage I · NSCLC, Stage I

#NSCLCStageI#Antibody#Phase2#monoclonal-antibody#NSCLC+2
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

Serplulimab combined with bevacizumab and first-line chemotherapy (Serplulimab combined with bevacizumab and first-line chemotherapy)

Non-small Cell Lung Cancer Stage II; Bevacizumab · Non-small Cell Lung Cancer Stage II

#Non-smallCellLungCancerStageII#Antibody#Phase3#monoclonal-antibody#Bevacizumab+1
Trials 1Status Active
AntibodyLimited DatastaleBeijing Chest HospitalPhase 2

Surufatinib Durvalizumab EP/EC (Surufatinib Durvalizumab EP/EC)

Extensive-stage Small-cell Lung Cancer · Extensive-stage Small-cell Lung Cancer

#Extensive-stageSmall-cellLungCan#Antibody#Phase2#monoclonal-antibody#Beijing
Trials 1Status Active
AntibodyLimited DatastaleBeiGenePhase 2

Tislelizumab combined with chemotherapy (Tislelizumab combined with chemotherapy)

Rectal Cancer; Rectal Cancer Stage II · Rectal Cancer

#RectalCancer#Antibody#Phase2#monoclonal-antibody#RectalCancerStageII+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNorthwestern UniversityPhase 1

Transferrin Receptor-Targeted Liposomal p53 cDNA (Transferrin Receptor-Targeted Liposomal p53 cDNA)

Anatomic Stage IV Breast Cancer AJCC v8; Breast Inflammatory Carcinoma · Anatomic Stage IV Breast Cancer AJCC v8

#AnatomicStageIVBreastCancerAJCCv#Antibody#Phase1#monoclonal-antibody#BreastInflammatoryCarcinoma+1
Trials 1Status Discontinued
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 1

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Ziv-Aflibercept)

Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Colorectal Carcinoma · FRα

#FR#Antibody#Phase1#monoclonal-antibody#ClinicalStageIVCutaneousMelanoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 2

apolizumab (apolizumab)

Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Small Lymphocytic Lymphoma · FRα

#FR#Antibody#Phase2#monoclonal-antibody#NoncontiguousStageIISmallLymphoc+2
Trials 1Status Active
AntibodyLimited DatastaleCancer Institute and Hospital, …Phase 2

cadonilimab，bevacizumab，docetaxel (cadonilimab，bevacizumab，docetaxel)

Stage IVB Lung Cancer; Non-Squamous · Stage IVB Lung Cancer

#StageIVBLungCancer#Antibody#Phase2#monoclonal-antibody#Non-Squamous+1
Trials 1Status Recruiting
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 2

cixutumumab (cixutumumab)

Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer · Recurrent Non-small Cell Lung Cancer

#RecurrentNon-smallCellLungCancer#Antibody#Phase2#monoclonal-antibody#StageIIIBNon-smallCellLungCancer+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, pertuzumab + trastuzumab + docetaxel)

Non Small Cell Lung Cancer Metastatic; Non Small Cell Lung Cancer Stage III · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#NonSmallCellLungCancerMetastatic+2
Trials 1Status Active

2 / 3 pages

← PreviousNext →